Yıl: 2022 Cilt: 21 Sayı: 1 Sayfa Aralığı: 1 - 7 Metin Dili: İngilizce DOI: 10.4274/eajem.galenos.2020.27880 İndeks Tarihi: 16-06-2022

Management of Arrhythmias in COVID-19

Öz:
Coronavirus disease-2019 (COVID-19) disease is caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) virus infection and firstly appeared in China and then became a pandemic. The leading cause of mortality is respiratory failure in COVID-19; however, cardiovascular manifestations are frequent and also important causes of death in COVID-19. The incidence of arrhythmia is increased in patients with COVID-19 due to increased systemic inflammatory response, hypoxia, and administered drugs. All kinds of arrhythmias, including bradyarrhythmias, supraventricular and ventricular arrhythmias, may develop during COVID-19 course. QT prolongation plays a central role in COVID-19 related arrhythmias. Therefore, QT duration should be strictly followed. All the clinicians should know the management of arrhythmias that they might face with frequently during the pandemic.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık
  • 1. Lazzerini PE, Boutjdir M, Capecchi PL. COVID-19, Arrhythmic risk, and inflammation: mind The gap! Circulation. 2020;142:7-9.
  • 2. Driggin E, Madhavan MV, Bikdeli B, Chuich T, Laracy J, Biondi-Zoccai G, et al. Cardiovascular considerations for patients, health care workers, and health systems during the coronavirus disease 2019 (COVID-19) pandemic. J Am Coll Cardiol. 2020;75:2352-71.
  • 3. Si D, Du B, Ni L, Yang B, Sun H, Jiang N, et al. Death, discharge, and arrhythmias among patients with COVID-19 and cardiac injury. CMAJ. 2020;cmaj.200879.
  • 4. Bhatla A, Mayer MM, Adusumalli S, Lin D, Marchlinski F, Deo R, et al. COVID-19 and Cardiac Arrhythmias. Heart Rhythm. 2020;S1547-5271:30594-4.
  • 5. Lazzerini PE, Laghi-Pasini F, Boutjdir M, Capecchi PL. Cardioimmunology of arrhythmias: the role of autoimmune and inflammatory cardiac channelopathies. Nat Rev Immunol. 2019;19:63-4.
  • 6. Colon CM, Barrios JG, Chiles JW, McElwee SK, Russell DW, Maddox WR, et al. Atrial arrhythmias in COVID-19 patients. JACC Clin Electrophysiol. 2020;6:1189-90.
  • 7. The European Society for Cardiology. ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic. Available from: https://www.escardio.org/The-ESC/Press-Office/Press-releases/ESC-Guidancefor-the-Diagnosis-and-Management-of-Heart-Disease-during-COVID- 19
  • 8. Duchin K, Duggal A, Atiee GJ, Kidokoro M, Takatani T, Shipitofsky NL, et al. An open-label crossover study of the pharmacokinetics of the 60-mg edoxaban tablet crushed and administered either by a nasogastric tube or in apple puree in healthy adults. Clin Pharmacokinet. 2018;57:221-8.
  • 9. Song Y, Wang X, Perlstein I, Wang J, Badawy S, Frost C, et al. Relative Bioavailability of Apixaban Solution or Crushed Tablet Formulations Administered by Mouth or Nasogastric Tube in Healthy Subjects. Clin Ther. 2015;37:1703-12.
  • 10. Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5:811-8.
  • 11. Song MK, Bae EJ, Baek JS, Kwon BS, Kim GB, Noh CI, et al. QT prolongation and life threatening ventricular tachycardia in a patient injected with intravenous meperidine (Demerol®). Korean Circ J. 2011;41:342-5.
  • 12. Viskin S. The QT interval: too long, too short or just right. Heart Rhythm. 2009;6:711-5.
  • 13. Chakravarty S, Kluger J, Chhabra L, Ramu B, Coleman C. Corrected QT in ventricular paced rhythms: what is the validation for commonly practiced assumptions? Cardiology. 2015;130:207-10.
  • 14. Thomas SH, Behr ER. Pharmacological treatment of acquired QT prolongation and torsades de pointes. Br J Clin Pharmacol. 2016;81:420-7.
  • 15. Alexander LK, Keene BW, Yount BL, Geratz JD, Small JD, Baric RS. ECG changes after rabbit coronavirus infection. J Electrocardiol. 1999;32:21-32.
  • 16. Boriani G, Fauchier L, Aguinaga L, Beattie JM, Lundqvist CB, Cohen A, et al. Group ESCSD. European Heart Rhythm Association (EHRA) consensus document on management of arrhythmias and cardiac electronic devices in critically ill and post-surgery patients, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society. Europace. 2019;21:7-8.
  • 17. Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8:475-81.
  • 18. Paulussen AD, Gilissen RA, Armstrong M, Doevendans PA, Verhasselt P, Smeets HJM, et al. Genetic variations of KCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2 in drug-induced long QT syndrome patients. J Mol Med (Berl). 2004;82:182-8.
  • 19. Yang T, Roden DM. Extracellular potassium modulation of drug block of IKr: implications for torsade de pointes and reverse use-dependence. Circulation. 1996; 93:407-11.
  • 20. Amin AS, Herfst LJ, Delisle BP, Klemens CA, Rook MB, Bezzina CR, et al. Feverinduced QTc prolongation and ventricular arrhythmias in individuals with type 2 congenital long QT syndrome. J Clin Invest. 2008;118:2552-61.
  • 21. Antzelevitch C, Yan GX, Ackerman MJ, Borggrefe M, Corrado D, Guo J, et al. J-wave syndromes expert consensus conference report: emerging concepts and gaps in knowledge. Heart Rhythm. 2016;13:e295-324.
  • 22. Mizusawa Y, Morita H, Adler A, Havakuk O, Thollet A, Maury P, et al. Prognostic significance of fever-induced Brugada syndrome. Heart Rhythm. 2016;13:1515-20.
  • 23. Wu CI, Postema PG, Arbelo E, Behr ER, Bezzina CR, Napolitano C, et al. SARSCoV-2, COVID-19, and inherited arrhythmia syndromes. Heart Rhythm. 2020;S1547-5271:30285-X.
  • 24. van der Werf C, Wilde AAM. Catecholaminergic polymorphic ventricular tachycardia:from bench to bedside. Heart. 2013;99:497
  • 25. Kobayashi S, Susa T, Ishiguchi H, Myoren T, Murakami W, Kato T, et al. A low-dose b1-blocker in combination with milrinone improves intracellular Ca21 handling in failing cardiomyocytes by inhibition of milrinoneinduced diastolic Ca21 leakage from the sarcoplasmic reticulum. PLoS One. 2015;10:e0114314.
APA ŞENER Y, Canpolat U, YORGUN H, AYTEMIR K (2022). Management of Arrhythmias in COVID-19 . , 1 - 7. 10.4274/eajem.galenos.2020.27880
Chicago ŞENER Yusuf Ziya,Canpolat Ugur,YORGUN HIKMET,AYTEMIR KUDRET Management of Arrhythmias in COVID-19 . (2022): 1 - 7. 10.4274/eajem.galenos.2020.27880
MLA ŞENER Yusuf Ziya,Canpolat Ugur,YORGUN HIKMET,AYTEMIR KUDRET Management of Arrhythmias in COVID-19 . , 2022, ss.1 - 7. 10.4274/eajem.galenos.2020.27880
AMA ŞENER Y,Canpolat U,YORGUN H,AYTEMIR K Management of Arrhythmias in COVID-19 . . 2022; 1 - 7. 10.4274/eajem.galenos.2020.27880
Vancouver ŞENER Y,Canpolat U,YORGUN H,AYTEMIR K Management of Arrhythmias in COVID-19 . . 2022; 1 - 7. 10.4274/eajem.galenos.2020.27880
IEEE ŞENER Y,Canpolat U,YORGUN H,AYTEMIR K "Management of Arrhythmias in COVID-19 ." , ss.1 - 7, 2022. 10.4274/eajem.galenos.2020.27880
ISNAD ŞENER, Yusuf Ziya vd. "Management of Arrhythmias in COVID-19 ". (2022), 1-7. https://doi.org/10.4274/eajem.galenos.2020.27880
APA ŞENER Y, Canpolat U, YORGUN H, AYTEMIR K (2022). Management of Arrhythmias in COVID-19 . Eurasian Journal of Emergency Medicine, 21(1), 1 - 7. 10.4274/eajem.galenos.2020.27880
Chicago ŞENER Yusuf Ziya,Canpolat Ugur,YORGUN HIKMET,AYTEMIR KUDRET Management of Arrhythmias in COVID-19 . Eurasian Journal of Emergency Medicine 21, no.1 (2022): 1 - 7. 10.4274/eajem.galenos.2020.27880
MLA ŞENER Yusuf Ziya,Canpolat Ugur,YORGUN HIKMET,AYTEMIR KUDRET Management of Arrhythmias in COVID-19 . Eurasian Journal of Emergency Medicine, vol.21, no.1, 2022, ss.1 - 7. 10.4274/eajem.galenos.2020.27880
AMA ŞENER Y,Canpolat U,YORGUN H,AYTEMIR K Management of Arrhythmias in COVID-19 . Eurasian Journal of Emergency Medicine. 2022; 21(1): 1 - 7. 10.4274/eajem.galenos.2020.27880
Vancouver ŞENER Y,Canpolat U,YORGUN H,AYTEMIR K Management of Arrhythmias in COVID-19 . Eurasian Journal of Emergency Medicine. 2022; 21(1): 1 - 7. 10.4274/eajem.galenos.2020.27880
IEEE ŞENER Y,Canpolat U,YORGUN H,AYTEMIR K "Management of Arrhythmias in COVID-19 ." Eurasian Journal of Emergency Medicine, 21, ss.1 - 7, 2022. 10.4274/eajem.galenos.2020.27880
ISNAD ŞENER, Yusuf Ziya vd. "Management of Arrhythmias in COVID-19 ". Eurasian Journal of Emergency Medicine 21/1 (2022), 1-7. https://doi.org/10.4274/eajem.galenos.2020.27880